Actively Recruiting
Evaluating Baxdrostats Effect on 24-Hour Blood Pressure in Chinese Adults with Uncontrolled Hypertension Taking Multiple Medications
Led by AstraZeneca · Updated on 2026-10-15
286
Participants Needed
51
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the effect of baxdrostat, a drug taken once daily, compared to a placebo on lowering 24-hour average systolic blood pressure SBP in adults with uncontrolled hypertension. This condition means their blood pressure remains high despite using two or more antihypertensive medications from different classes without diuretics. The study is a Phase IIIb, randomized, double-blind, placebo-controlled trial conducted across multiple centers in China. Participants will first go through a screening period lasting up to 4 weeks, followed by a 4-week run-in phase where they take a placebo. After this, they will be randomly assigned to receive either baxdrostat 2 mg or placebo orally once daily for 12 weeks while continuing their background blood pressure medications without dose changes, except in cases of low blood pressure symptoms. Rescue therapy is allowed if blood pressure becomes dangerously high, excluding certain diuretics. After treatment, a 2-week safety follow-up will be conducted. The total participation time is approximately 22 weeks. During the study, participants will have their blood pressure monitored, including ambulatory 24-hour average SBP as the primary outcome at week 12. Other assessments include nighttime and daytime blood pressure, seated blood pressure, and safety monitoring for adverse events, including special focus on potassium and sodium levels. Adherence to medication will be tracked, and safety will be overseen by a dedicated committee. Participants health status will be followed through the end of the study period.
CONDITIONS
Brief Title
A Phase IIIb Study to Investigate the Effect of Baxdrostat in Chinese Participants With Uncontrolled Hypertension.
Research Team
A
AstraZeneca Clinical Study Information Center
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here